R&D Systems Recombinant Human CD2 Fc Chimera Protein, CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems 1856CD050
DescriptionThe Recombinant Human CD2 Fc Chimera Protein is derived from HEK293. The Recombinant Human CD2 Fc Chimera Protein has been validated for the following applications: Bioactivity.
|12 months from date of receipt, <= -20 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution.|
|<0.10 EU per 1 μg of the protein by the LAL method.|
|Reconstitute at 200 μg/mL in PBS.|
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.|
|Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.|